Payers Expect Clearer Demonstration of Health Technology Benefits
Sweden and Finland are leaders in developing and applying health technology and provide ideal environments for conducting Health Technology Assessments (HTA) for medical devices.
Health Economic Modelling
Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization.
Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization. With the help of modelling, fragmented research data, observations, and experiences, as well as justified assumptions, are compiled into a synthesis that aims to anticipate and predict the impact of healthcare interventions on individuals, patient groups, healthcare and society.
Modelling not only answers the decision maker’s question about the most likely outcome, but also the probability of extreme scenarios, as well as the credible range of results. In its most general form, modelling relates to the cost-effectiveness of an intervention. This means that the costs are examined together with the health benefits of the intervention. Another common target of modelling is the budget impact of an intervention. In this case, the focus is on the intervention’s impact on the use of resources. These can be even directly related to the intervention, or indirectly to the entire treatment path of a patient.
Medaffcon has the ability to complete modelling projects from the localization of the customer’s ready global core models to the comprehensive construction of models from the beginning. We have been doing modelling for over 10 years, providing our customers with an effective tool to support decision making.
Read more about our interactive value tools that combine health economic modelling, real world evidence and data science into one easy to use product.
The final outcomes of Health Economic Modelling projects are used in:
- authority contexts
- negotiations with decision-makers and payers at different levels
- the support of sales and marketing, for example, in material production or tailor-made tools used in sales situations
“Modeling enables the combination of information from multiple sources and thus the evaluation of effectiveness and cost-effectiveness. The analysis can be based on any kind of information, such as the results of clinical trials or real world data.”
“The purpose of modelling is to provide tools for the clients and decision makers for managing and predicting future uncertainty. Modelling provides information for decision-making and for discussions with public authorities and healthcare payers.”
Related articles
-
-
Medaffcon’s Patient Dynamics Tool Helps Focus and Find the Right Actions
Are you employed in the pharmaceutical industry and seeking insights into your product's position within the Finnish market? Then Patient Dynamics is the ideal tool for you. Developed by Medaffcon, Patient Dynamics caters to the needs of pharmaceutical companies by providing precise information for sales and marketing decision-making.
-
Renewable drug therapy challenges the current complex drug evaluation system
“Renewable drug therapy challenges the current complex drug evaluation system,” states Lauri Pelkonen, a leading expert at the Ministry of Social Affairs and Health (STM). For this reason, the evaluation activity is being reformed to better respond to changes in the operating environment.
